Press Releases

Date Title and Summary Additional Formats
12/06/18 Aquaculture Acquisition to Create Vaccine Innovation Powerhouse
Phibro Animal Health Acquires Fish Vaccine Business of KoVax TEL AVIV, Israel , Dec. 06, 2018 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced it has acquired the assets of KoVax Ltd. , an Israel -based developer and manufacturer of vaccines for the global
View HTML
01/09/19 Canada Approves Phibro Solution for Beef Cattle
Teaneck, New Jersey (January 9, 2019) – V-Max™ (Virginiamycin) medicated feed additive has received regulatory approval by the Veterinary Drugs Directorate (VDD), Health Canada for use in beef cattle. V-Max is approved for the reduction of incidence of liver abscesses in cattle fed in confinement, which is a condition that affects the well-being of an estimated one in five feedlot cattle in Canada. 
08/01/19 Phibro Animal Health Corporation Acquires Business of Osprey Biotechnics, Inc.
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (“Phibro”) (NASDAQ:PAHC) today announced it has acquired the business and assets of Osprey Biotechnics, Inc. (“Osprey”), a privately held developer and marketer of innovative microbial products.
View HTML
11/19/13 Phibro Animal Health Corporation and Epitopix, LLC form Poultry Vaccine Partnership
Phibro Animal Health Corporation and Epitopix, LLC form Poultry Vaccine Partnership Teaneck, NJ and Willmar, MN – November 19, 2013 Phibro Animal Health Corporation and Epitopix have entered into a partnership to manufacture and market biological products for chickens in the United States based on
View HTML
07/05/17 Phibro Animal Health Corporation and Zydus Cadila announce their intention to license Phibro's Poultry Vaccine Technologies
TEL AVIV, Israel and AHMEDABAD, India, July 05, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:PAHC) Phibro Animal Health Corporation and Zydus Cadila today announced their intention to enter into a long-term arrangement to license Phibro's innovative poultry vaccine technologies and know-how to a new vaccine
View HTML
07/08/19 Phibro Animal Health Corporation Announces a Significant Advance in the Development of a Vaccine Against African Swine Fever
TEANECK, N.J. , July 08, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced it is pursuing patent protection following a significant advance in the on-going development of a vaccine for African Swine Fever (ASF).  This important step in the vaccine development
View HTML
01/25/16 Phibro Animal Health Corporation Announces Closing of Acquisition of Business of MVP Laboratories, Inc.
TEANECK, N.J., Jan. 25, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation ("Phibro") (NASDAQ:PAHC) today announced it has completed its purchase of the assets of MVP Laboratories, Inc. ("MVP"), a developer, manufacturer and marketer of livestock vaccines, vaccine adjuvants and other
View HTML
01/22/15 Phibro Animal Health Corporation Announces Entry Into Collaboration Agreement, License Agreement and Intellectual Property Acquisition Agreement
TEANECK, N.J. , Jan. 22, 2015 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation ("Phibro") (Nasdaq:PAHC) today announced it has acquired exclusive North American distribution rights for vaccines using MJ Biologicals, Inc.'s ("MJB") vaccine technologies focused on the swine industry and
View HTML
05/31/16 Phibro Animal Health Corporation Announces Gerald Carlson Retirement, Larry Miller Promotion
TEANECK, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ:PAHC) today announced that Gerald Carlson, Chief Operating Officer, will retire after 14 years with Phibro, effective July 1, 2016.  Jack Bendheim, Phibro's Chairman, President and Chief Executive Officer
View HTML
01/20/14 Phibro Animal Health Corporation announces its Phibro Aquaculture Business Unit, led by Dr. Ra’anan Ariav, and the Acquisition of the Assets of AquaVet Ltd.
Phibro Animal Health Corporation announces its Phibro Aquaculture Business Unit, led by Dr. Ra’anan Ariav, and the Acquisition of the Assets of AquaVet Ltd. Teaneck, NJ – January 20, 2014 Phibro Animal Health Corporation announced today that it has acquired the aquaculture assets of AquaVet Ltd., a
View HTML